<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-LM7WE4FS</identifier><date>2019</date><creator>Mlinarič-Raščan, Irena</creator><creator>Šmid, Alenka</creator><creator>Urbančič, Dunja</creator><relation>documents/doc/L/URN_NBN_SI_doc-LM7WE4FS_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-LM7WE4FS_001.txt</relation><format format_type="issue">3</format><format format_type="volume">70</format><format format_type="type">article</format><format format_type="extent">str. 220-227</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">4766065</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-LM7WE4FS</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">farmakogenomika</subject><subject language_type_id="slv">genetski polimorfizmi</subject><subject language_type_id="slv">S-adenozilmetionin</subject><subject language_type_id="slv">tiopurin S-metiltransferaza</subject><subject language_type_id="slv">tiopurini</subject><title>Farmakogenomsko vrednotenje tiopurinov</title><title>Pharmacogenomic evaluation of thiopurines</title></Record>